221 related articles for article (PubMed ID: 16916424)
1. Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
Keltner NL
Perspect Psychiatr Care; 2006 Aug; 42(3):204-7. PubMed ID: 16916424
[No Abstract] [Full Text] [Related]
2. When essential medications provoke new health problems: the metabolic effects of second-generation antipsychotics.
Stein K
J Am Diet Assoc; 2010 Jul; 110(7):992-1001. PubMed ID: 20630154
[No Abstract] [Full Text] [Related]
3. Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?
Housel AK; Waterbury N; Argo TR
Issues Ment Health Nurs; 2009 Dec; 30(12):803-5. PubMed ID: 19916816
[No Abstract] [Full Text] [Related]
4. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
Yogaratnam J; Biswas N; Vadivel R; Jacob R
East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring of patients using atypical psychotics and screening for metabolic syndrome].
Legrix D
Soins Psychiatr; 2010; (266):25-9. PubMed ID: 20162964
[No Abstract] [Full Text] [Related]
6. Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
Monteleone P; Martiadis V; Maj M
Psychiatr Clin North Am; 2009 Dec; 32(4):775-94. PubMed ID: 19944883
[TBL] [Abstract][Full Text] [Related]
7. The effect of antipsychotic medication on metabolic syndrome.
Jones M; Jones A
Nurs Stand; 2008 Aug 6-12; 22(48):43-8. PubMed ID: 18727355
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
Bou Khalil R
Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome and schizophrenia.
Meyer JM; Stahl SM
Acta Psychiatr Scand; 2009 Jan; 119(1):4-14. PubMed ID: 19133915
[TBL] [Abstract][Full Text] [Related]
10. Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes.
Edward KL; Rasmussen B; Munro I
Arch Psychiatr Nurs; 2010 Feb; 24(1):46-53. PubMed ID: 20117688
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
[No Abstract] [Full Text] [Related]
12. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia, the metabolic syndrome and diabetes.
Holt RI; Peveler RC; Byrne CD
Diabet Med; 2004 Jun; 21(6):515-23. PubMed ID: 15154933
[TBL] [Abstract][Full Text] [Related]
14. Medication-induced weight gain and dyslipidemia in patients with schizophrenia.
Fenton WS; Chavez MR
Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676
[No Abstract] [Full Text] [Related]
15. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
16. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
17. The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management.
Usher K; Foster K; Park T
J Psychiatr Ment Health Nurs; 2006 Dec; 13(6):730-4. PubMed ID: 17087676
[TBL] [Abstract][Full Text] [Related]
18. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic syndrome in patients with schizophrenia and antipsychotic treatment].
Aguilar E; Coronas R; Caixàs A
Med Clin (Barc); 2012 Nov; 139(12):542-6. PubMed ID: 22841467
[TBL] [Abstract][Full Text] [Related]
20. Weight gain and metabolic syndrome among young patients on antipsychotic medication: what do we know and where do we go?
Eapen V; John G
Australas Psychiatry; 2011 Jun; 19(3):232-5. PubMed ID: 21682621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
